RPE65 mutations account for approximately 0.6–6% of RP cases and for 3–16% of LCA/EORD cases depending on the analyzed cohort [9,10,19,29,31,36,37,38,41,42]. This evidence concerns the gene RPE65 and Leber congenital amaurosis.